Related Experiment Video
Updated: Jun 17, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
[What I have learned and accomplished through research on multiple sclerosis (MS)]
1Department of Neurology, Tohoku University.
Rinsho Shinkeigaku = Clinical Neurology
|December 25, 2009
Summary
Neuromyelitis optica (NMO) and optic spinal MS (OSMS) are distinct from multiple sclerosis (MS). NMO/OSMS involves aquaporin 4 (AQP4) antibody-driven astrocytic damage, unlike MS, which is primarily a demyelinating disease.
Area of Science:
- Neuroimmunology
- Neuropathology
Context:
- Multiple sclerosis (MS) is a central nervous system (CNS) inflammatory demyelinating disease with unknown etiology.
- Optic spinal MS (OSMS) is prevalent in Japan, leading to debate on its relation to neuromyelitis optica (NMO).
Purpose:
- To investigate the distinction between MS and NMO/OSMS.
- To elucidate the role of NMO-IgG and aquaporin 4 (AQP4) in NMO/OSMS pathogenesis.
Summary:
- NMO-IgG, specific to NMO/OSMS patients, targets aquaporin 4 (AQP4) on astrocytes.
- Lesions in NMO/OSMS show AQP4 and GFAP loss, indicating astrocytic damage, contrasting with MS lesions.
- GFAP levels in CSF are elevated in acute NMO/OSMS but not in MS.
Impact:
- NMO/OSMS is proposed as a distinct disease from MS, characterized by AQP4 antibody-mediated astrocytic injury.
- Findings differentiate NMO/OSMS from MS, offering new insights into their distinct pathomechanisms.
